Wellington Management Group
JBIO

Wellington Management Group’s Jade Biosciences JBIO Stock Holding History

Wellington Management Group’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.81M Buy
129,166
+26,546
+26% +$384K ﹤0.01% 1569
2025
Q4 		$1.58M Sell
102,620
-4,933
-5% -$57.9K ﹤0.01% 1645
2025
Q3 		$928K Buy
+107,553
New +$879K ﹤0.01% 1792

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group's JBIO Position: Q1 2026 in Review

Wellington Management Group increased its Jade Biosciences (JBIO) stake by 26% in Q1 2026, buying an estimated $384K and bringing the position to 129,166 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1569.

Wellington Management Group first reported a position in JBIO in Q3 2025 and has held it in 3 quarters since. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Wellington Management Group held 129,166 shares of Jade Biosciences worth $1.81M as of Q1 2026.
  • Wellington Management Group bought 26,546 Jade Biosciences shares in Q1 2026, an estimated $384K.
  • Jade Biosciences made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1569 holding.
  • Wellington Management Group first reported a position in Jade Biosciences in Q3 2025 and has held it in 3 quarters since.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.